Thursday, February 28, 2013

APPLE CEO SAYS HE FEELS SHAREHOLDER'S PAIN, URGES LONG VIEW



Apple Inc CEO Tim Cook on Wednesday acknowledged widespread disappointment in the company’s sagging share price but shared few details about its secretive product pipeline and touched only briefly on a raging debate about how best to reward shareholders.
The world’s most valuable technology company headed into its annual shareholders’ meeting at its headquarters on shakier ground than it has been accustomed to in years, since the iPhone and iPad helped vault the company to premier investment status.

A declining share price has lent weight to Wall Street’s demand that it share more of its $137 billion in cash and securities pile – equivalent to Hungary’s Gross Domestic Product, and growing – a debate now spearheaded by outspoken hedge fund manager David Einhorn.
Einhorn was not spotted at the meeting at the company’s headquarters at 1 Infinite Loop in Cupertino. Cook repeated that the company’s board remained in “very very active” discussions about options for cash sharing, and said he shared investors’ dissatisfaction over the stock price.
“I don’t like it either. The board doesn’t like it. The management team doesn’t like it,” Cook told investors.
“What we are focused on is the long term. This has always been a secret of Apple.”
By focusing on the long term, revenue and profit will follow, he said.
Apple had the “mother of all years” last year with growth, in terms of dollars, outpacing that of Microsoft Corp, Google Inc, Nokia and several other major technology companies combined, Cook said.
Cook — who was re-elected to the board with 99.1 percent of shareholder votes — added that the company was working on new product categories, but, as usual, would not elaborate.
Speculation is rife on Wall Street and in Silicon Valley that the iPhone maker is working on a project to revolutionize the television and TV content, or a smart “iWatch.”
Apple’s stock was down 0.25 percent to $447.86 in afternoon trade. It is now down more than 35 percent from its $702.10 September peak.

2 comments:

  1. each time i used to read smaller articles that as well clear their motive, and
    that is also happening with this piece of writing which I am reading at
    this time.

    Review my web-site ... Computer Support

    ReplyDelete
  2. These medicines aren't the permanent gout treatment due to the fact as soon as you halt having it, it arrives back. And any issue together with your kidneys that interferes with their capacity to hold out their operate efficiently means that, in spite of typical levels of uric acid production, not enough acid is being flushed from your body. Simply rising the quantity of medication didn't seem like a worthwhile exercise - what if you'll find negative effects? Absolutely if I'm rising
    the efficiency, I am rising the risk? What also appeared odd to me was that this
    medical professional, when giving me prescriptions for my meds, was also throwing in a script
    for anti-inflammatory "just in case you need to do get an attack".


    my web blog - gout tophi

    ReplyDelete